Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency
Synonyms: COXPD10 · Combined oxidative phosphorylation defect type 10
- Type
- Disease
- Group
- Disorder
- Inheritance
- Unknown
- Age of onset
- Infancy, Neonatal
- Status
- active
A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by lactic acidosis, hypotonia, hypertrophic cardiomyopathy and global developmental delay. Other clinical features include feeding difficulties, failure to thrive, seizures, optic atrophy and ataxia.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency | COXPD10 · Combined oxidative phosphorylation defect type 10 |
| fr | Cardiomyopathie hypertrophique mitochondriale avec acidose lactique par déficit en MTO1 | COXPD10 · Déficit combiné de la phosphorylation oxydative type 10 |
| de | Kardiomyopathie, hypertrophe mitochondriale, mit Laktatazidose durch MTO1-Mangel | COXPD10 · Kombinierten Defekt der oxidativen Phosphorylierung Typ 10 · OXPHOS-Defekt, kombinierter, Typ 10 |
| es | Miocardiopatía hipertrófica mitocondrial con acidosis láctica por deficiencia de MTO1 | COXPD10 · Deficiencia combinada de la fosforilación oxidativa tipo 10 |
| it | Cardiomiopatia ipertrofica mitocondriale con acidosi lattica da deficit di MTO1 | COXPD10 · Difetto combinato della fosforilazione ossidativa, tipo 10 |
| nl | Mitochondriale hypertrofische cardiomyopathie met lactaatacidose door MTO1-deficiëntie | COXPD10 · Gecombineerde oxidatieve fosforylatiedeficiëntie type 10 |
| pt | Miocardiopatía hipertrófica mitocondrial com acidose láctica por défice de MTO1 | COXPD10 · Defeito OXPHOS combinado tipo 10 · Defeito combinado da fosforilação oxidativa tipo 10 · Deficiência de OXPHOS combinado tipo 10 |
| pl | Mitochondrialna kardiomiopatia przerostowa z kwasicą mleczanową spowodowana niedoborem MTO1 | COXPD10 · Złożony defekt fosforylacji oksydacyjnej typu 10 |
| cs | Mitochondriální hypertrofická kardiomyopatie s laktátovou acidózou, způsobená deficitem MTO1 | COXPD10 · Kombinovaná porucha oxidativní fosforylace, typ 10 |
| uk | Мітохондріальна гіпертрофічна кардіоміопатія з молочнокислим ацидозом, зумовлена дефіцитом MTO1 | Комбінований дефект окисного фосфорилювання, тип 10 · COXPD10 |
| zh | 线粒体肥大型心肌病伴MTO1基因缺陷所致乳酸酸中毒 | 联合氧化磷酸化缺陷10型 |
| tr | MTO1 eksikliğine bağlı laktik asidoz ile seyreden mitokondriyal hipertrofik kardiyomiyopati | COXPD10 · Kombine oksidatif fosforilasyon defekti tip 10 |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 614702 | E | validated | |
| ICD-10 | E88.8 | NTBT | attributed | validated |
| ICD-11 | 5C53.2Y | NTBT | attributed | validated |
| MONDO | 0013865 | E | validated | |
| UMLS | C4749921 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (2):
- ORPHA:217587Mitochondrial disease with hypertrophic cardiomyopathy
rare cardiac diseases; rare genetic diseases; rare transplant-related disorders - ORPHA:35696Mitochondrial disorder due to a defect in mitochondrial protein synthesis
rare inborn errors of metabolism; rare genetic diseases
No children.
Genes
1 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| MTO1 | Disease-causing germline mutation(s) in | Assessed | HGNC:19261 | ENSG00000135297 | 614667 | 6q13 | mitochondrial tRNA translation optimization 1 |
Prevalence and incidence
2 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Cases/families | 8 cases | Worldwide | Case(s) | Validated | 23929671[PMID] | |
| Point prevalence | <1 / 1 000 000 | — | Worldwide | Class only | Validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
18 annotations · validated 2026-01-07| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0008347 | Decreased activity of mitochondrial complex IV | |
| HP:0001639 | Hypertrophic cardiomyopathy | |
| HP:0003128 | Lactic acidosis | |
| Frequent (79-30%) | ||
| HP:0011923 | Decreased activity of mitochondrial complex I | |
| HP:0001298 | Encephalopathy | |
| HP:0001531 | Failure to thrive in infancy | |
| HP:0008872 | Feeding difficulties in infancy | |
| HP:0001263 | Global developmental delay | |
| HP:0003348 | Hyperalaninemia | |
| HP:0001252 | Hypotonia | |
| HP:0001249 | Intellectual disability | |
| HP:0000648 | Optic atrophy | |
| HP:0001250 | Seizure | |
| Occasional (29-5%) | ||
| HP:0001251 | Ataxia | |
| HP:0001943 | Hypoglycemia | |
| HP:0002919 | Ketonuria | |
| HP:0002465 | Poor speech | |
| HP:0001716 | Wolff-Parkinson-White syndrome | |
Run the differential on the 3 obligate / very frequent terms
Annotation source: 34990597[PMID]_29331171[PMID]_23929671[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/314637
- This record as JSON: /data/d/314637.json